Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACHIEVE 2/3: Albumin Interferon vs Peginterferon in CHC Genotype 2/3
NCT00411385Phase 3Completed
- Sponsor
- Human Genome Sciences
- Start
- Feb 2007
- Primary completion
- Oct 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 21
01
Overview
A Phase 3 trial of albinterferon alfa-2b in hepatitis C (HCV), sponsored by Human Genome Sciences. Started Feb 2007; status: completed.
02
Drugs
albinterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00411385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411385.